Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
Provided By GlobeNewswire
Last update: Dec 19, 2024
Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial
Lifecore to Leverage Differentiated Capabilities and Knowledge in Fill and Finish to Support Nirsum’s NIH-Funded NRS-033 Development Program
Read more at globenewswire.com6.18
+0.14 (+2.32%)
Find more stocks in the Stock Screener
LFCR Latest News and Analysis
18 days ago - ChartmillWhich stocks are experiencing notable movement on Friday?Stay up-to-date with the latest market trends in the middle of the day on Friday. Explore the top gainers and losers during today's session in our detailed report.
18 days ago - ChartmillWhich stocks are gapping on Friday?The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
